Cargando…

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Allison L., Wenger, Julia B., James-Todd, Tamarra, Lamparello, Brooke M., Halprin, Elizabeth, Serdy, Shanti, Fan, Shuling, Horowitz, Gary L., Lim, Kee-Hak, Rana, Sarosh, Takoudes, Tamara C., Wyckoff, Jennifer A., Thadhani, Ravi, Karumanchi, S. Ananth, Brown, Florence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare USA, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894714/
https://www.ncbi.nlm.nih.gov/pubmed/24354578
http://dx.doi.org/10.3109/10641955.2013.837175
_version_ 1782299883153129472
author Cohen, Allison L.
Wenger, Julia B.
James-Todd, Tamarra
Lamparello, Brooke M.
Halprin, Elizabeth
Serdy, Shanti
Fan, Shuling
Horowitz, Gary L.
Lim, Kee-Hak
Rana, Sarosh
Takoudes, Tamara C.
Wyckoff, Jennifer A.
Thadhani, Ravi
Karumanchi, S. Ananth
Brown, Florence M.
author_facet Cohen, Allison L.
Wenger, Julia B.
James-Todd, Tamarra
Lamparello, Brooke M.
Halprin, Elizabeth
Serdy, Shanti
Fan, Shuling
Horowitz, Gary L.
Lim, Kee-Hak
Rana, Sarosh
Takoudes, Tamara C.
Wyckoff, Jennifer A.
Thadhani, Ravi
Karumanchi, S. Ananth
Brown, Florence M.
author_sort Cohen, Allison L.
collection PubMed
description OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N = 159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th–75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N = 139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. RESULTS: PE developed in 12% (N = 19) and GHTN developed in 23% (N = 37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35–40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19–7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27–34 weeks 15.18 (2.37–26.86), at 35–40 weeks 8.61(1.20–18.27), p ≤ 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). CONCLUSIONS: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE.
format Online
Article
Text
id pubmed-3894714
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Informa Healthcare USA, Inc.
record_format MEDLINE/PubMed
spelling pubmed-38947142014-01-22 The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes Cohen, Allison L. Wenger, Julia B. James-Todd, Tamarra Lamparello, Brooke M. Halprin, Elizabeth Serdy, Shanti Fan, Shuling Horowitz, Gary L. Lim, Kee-Hak Rana, Sarosh Takoudes, Tamara C. Wyckoff, Jennifer A. Thadhani, Ravi Karumanchi, S. Ananth Brown, Florence M. Hypertens Pregnancy Original Article OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N = 159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th–75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N = 139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. RESULTS: PE developed in 12% (N = 19) and GHTN developed in 23% (N = 37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35–40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19–7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27–34 weeks 15.18 (2.37–26.86), at 35–40 weeks 8.61(1.20–18.27), p ≤ 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). CONCLUSIONS: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE. Informa Healthcare USA, Inc. 2014-02 2013-12-19 /pmc/articles/PMC3894714/ /pubmed/24354578 http://dx.doi.org/10.3109/10641955.2013.837175 Text en © 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Original Article
Cohen, Allison L.
Wenger, Julia B.
James-Todd, Tamarra
Lamparello, Brooke M.
Halprin, Elizabeth
Serdy, Shanti
Fan, Shuling
Horowitz, Gary L.
Lim, Kee-Hak
Rana, Sarosh
Takoudes, Tamara C.
Wyckoff, Jennifer A.
Thadhani, Ravi
Karumanchi, S. Ananth
Brown, Florence M.
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title_full The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title_fullStr The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title_full_unstemmed The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title_short The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
title_sort association of circulating angiogenic factors and hba1c with the risk of preeclampsia in women with preexisting diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894714/
https://www.ncbi.nlm.nih.gov/pubmed/24354578
http://dx.doi.org/10.3109/10641955.2013.837175
work_keys_str_mv AT cohenallisonl theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT wengerjuliab theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT jamestoddtamarra theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT lamparellobrookem theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT halprinelizabeth theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT serdyshanti theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT fanshuling theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT horowitzgaryl theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT limkeehak theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT ranasarosh theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT takoudestamarac theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT wyckoffjennifera theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT thadhaniravi theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT karumanchisananth theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT brownflorencem theassociationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT cohenallisonl associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT wengerjuliab associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT jamestoddtamarra associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT lamparellobrookem associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT halprinelizabeth associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT serdyshanti associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT fanshuling associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT horowitzgaryl associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT limkeehak associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT ranasarosh associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT takoudestamarac associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT wyckoffjennifera associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT thadhaniravi associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT karumanchisananth associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes
AT brownflorencem associationofcirculatingangiogenicfactorsandhba1cwiththeriskofpreeclampsiainwomenwithpreexistingdiabetes